| Absorption |
| Blood-Brain Barrier | BBB+ | 0.6390 |
| Human Intestinal Absorption | HIA+ | 0.9714 |
| Caco-2 Permeability | Caco2- | 0.6631 |
| P-glycoprotein Substrate | Substrate | 0.7964 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8324 |
| Inhibitor | 0.6601 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8617 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7797 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8503 |
| CYP450 2D6 Substrate | Non-substrate | 0.9115 |
| CYP450 3A4 Substrate | Substrate | 0.7206 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8952 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8909 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8903 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8513 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.6571 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7992 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8359 |
| Non-inhibitor | 0.6699 |
| AMES Toxicity | Non AMES toxic | 0.8927 |
| Carcinogens | Non-carcinogens | 0.9523 |
| Fish Toxicity | High FHMT | 0.9971 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9996 |
| Honey Bee Toxicity | High HBT | 0.8480 |
| Biodegradation | Not ready biodegradable | 0.8854 |
| Acute Oral Toxicity | III | 0.3559 |
| Carcinogenicity (Three-class) | Non-required | 0.7165 |